Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) Amortizatization of Intangibles (2016 - 2018)

Armata Pharmaceuticals' Amortizatization of Intangibles history spans 6 years, with the latest figure at $8000.0 for Q4 2018.

  • For Q4 2018, Amortizatization of Intangibles changed 0.0% year-over-year to $8000.0; the TTM value through Dec 2018 reached $31000.0, changed 0.0%, while the annual FY2018 figure was $31000.0, 0.0% changed from the prior year.
  • Amortizatization of Intangibles for Q4 2018 was $8000.0 at Armata Pharmaceuticals, roughly flat from $8000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $8000.0 in Q1 2014 and bottomed at $7000.0 in Q2 2016.
  • The 5-year median for Amortizatization of Intangibles is $8000.0 (2014), against an average of $7812.5.
  • The largest YoY upside for Amortizatization of Intangibles was 100.31% in 2014 against a maximum downside of 99.69% in 2014.
  • A 5-year view of Amortizatization of Intangibles shows it stood at $8000.0 in 2014, then changed by 0.0% to $8000.0 in 2015, then changed by 0.0% to $8000.0 in 2016, then changed by 0.0% to $8000.0 in 2017, then changed by 0.0% to $8000.0 in 2018.
  • Per Business Quant, the three most recent readings for ARMP's Amortizatization of Intangibles are $8000.0 (Q4 2018), $8000.0 (Q3 2018), and $7000.0 (Q2 2018).